Howard W Robin Insider Trading Activity

Corporate InsiderCEO · CIK 1206869

16

Total trades

$1.0M

Total volume

May 19, 2026

Last activity

NKTR

NEKTAR THERAPEUTICS

Howard W Robin has been net-selling over the last 12 months with 0 purchases and 16 sales across 1 company.

NKTR is the most-traded position with 16 trades. The largest single transaction was a sale of NKTR for $125K on Sep 5, 2025.

Performance Scorecard

Forward stock performance after each transaction by Howard W Robin. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-46.2%19%16
90 days-50.8%7%15
120 days-16.9%33%15

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

NKTR · NEKTAR THERAPEUTICS

🔒 Subscribe to see trade entries

Pro members see exactly when Howard W Robin bought and sold NKTR.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
May 19, 2026
NKTRSell444$65.51$29K−0.6%CEO
Feb 18, 2026
NKTRSell423$73.00$31K−0.6%CEO
Nov 25, 2025
NKTRSell2,207$54.28$120K−3.9%CEO
Sep 9, 2025
NKTRSell1,210$48.18$58K−2.4%CEO
Sep 9, 2025
NKTRSell2,156$47.49$102K−4.1%CEO
Sep 9, 2025
NKTRSell1,200$46.41$56K−2.2%CEO
Sep 9, 2025
NKTRSell2,100$45.16$95K−3.7%CEO
Sep 5, 2025
NKTRSell1,136$39.89$45K−2.0%CEO
Sep 5, 2025
NKTRSell2,226$38.82$86K−3.7%CEO
Sep 5, 2025
NKTRSell3,304$37.87$125K−5.3%CEO
Sep 4, 2025
NKTRSell1,496$33.54$50K−2.3%CEO
Sep 4, 2025
NKTRSell1,923$32.37$62K−2.8%CEO
Sep 4, 2025
NKTRSell613$34.40$21K−1.0%CEO
Sep 4, 2025
NKTRSell1,134$35.80$41K−1.8%CEO
Sep 2, 2025
NKTRSell1,500$30.16$45K−2.2%CEO
Aug 19, 2025
NKTRSell1,573$26.59$42K−2.2%CEO

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
NKTRNEKTAR THERAPEUTICS16$1.0M

Other insiders at NEKTAR THERAPEUTICS

1 other tracked filer at NKTR.